Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Pulsatile Tinnitus

2-amino-5-phosphonovalerate has been researched along with Pulsatile Tinnitus in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research Excerpts

ExcerptRelevanceReference
"In contrast, D-AP5-treated-tinnitus animals showed significantly less bilateral parafloccular and dorsal cochlear nucleus activity, as well as significantly less contralateral ventral cochlear nucleus activity."1.39Local NMDA receptor blockade attenuates chronic tinnitus and associated brain activity in an animal model. ( Bauer, CA; Brozoski, TJ; Odintsov, B; Wisner, KW, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brozoski, TJ1
Wisner, KW1
Odintsov, B1
Bauer, CA1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Pulsatile Tinnitus

ArticleYear
Local NMDA receptor blockade attenuates chronic tinnitus and associated brain activity in an animal model.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: 2-Amino-5-phosphonovalerate; Acoustic Stimulation; Animals; Auditory Cortex; Auditory Threshold; Cer

2013